Wave Life Sciences (WVE) Initiates Multidose Phase 2a for INLIGHTTM Trial

Wave Life Sciences Ltd. (NASDAQ:WVE) is one of the 10 best stocks under $10 offering more than 50% upside.

On June 24, Wave Life Sciences Ltd. (NASDAQ:WVE) began the Phase 2a multidose part of the INLIGHTTM trial. The study aims to assess WVE-007, an experimental GalNAc-siRNA, as a monotherapy in people with obesity (BMI 35–50 kg/m²) and associated comorbidities in this placebo-controlled (3:1) study.

Photo by Ian Hutchinson on Unsplash

An ongoing Phase 1 single-dose component of the INLIGHT trial is examining WVE-007 in normal, healthy people who are on the verge of obesity and have an average BMI of 32 kg/m². A sole 240 mg dose of WVE-007 sustained to produce clinically significant decreases in waist circumference (-3%), visceral fat (-14%; p<0.05), and total fat (-5%) at six months of follow-up in this section of the experiment.

Data suggest the possibility of a once or twice yearly dosage of WVE-007, which is still typically tolerable as well as safe up to 600 mg. Additional changes in human body composition, such as weight loss, enhanced biomarkers of cardiometabolic health, and increased fat loss with retained muscle, are anticipated in Phase 2a of the INLIGHT trial.

Wave Life Sciences Ltd. (NASDAQ:WVE) is involved in the development and commercialization of ribonucleic acid (RNA) medicines, focusing on RNA editing, splicing, and silencing. The company leverages its technology platform, PRISM, which ensures precision targeting of diseases and improvement of pharmacological properties through stereopure oligonucleotides.

While we acknowledge the risk and potential of WVE as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than WVE and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1